Serge A.L. Zander
- Oncology top 2%
- Molecular Biology top 10%
- Genetics top 10%
- Cancer Research top 10%
- Immunology
- Co-authors
- Jos JonkersPiet BorstSven RottenbergAriena KersbergenJanneke E. JaspersAaron CranstonMark J. O’ConnorNiall M.B. Martin
- Topics
- Cancer therapeutics and mechanisms (4 papers)DNA Repair Mechanisms (4 papers)Drug Transport and Resistance Mechanisms (3 papers)
- Partner nations
- NetherlandsUnited KingdomDenmark
In The Last Decade
Serge A.L. Zander
10 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 1.1k
- Molecular Biology 1.1k
- Genetics 286
- Cancer Research 165
- Immunology 158
Countries citing papers authored by Serge A.L. Zander
This map shows the geographic impact of Serge A.L. Zander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge A.L. Zander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge A.L. Zander more than expected).
Fields of papers citing papers by Serge A.L. Zander
This network shows the impact of papers produced by Serge A.L. Zander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge A.L. Zander. The network helps show where Serge A.L. Zander may publish in the future.
Co-authorship network of co-authors of Serge A.L. Zander
This figure shows the co-authorship network connecting the top 25 collaborators of Serge A.L. Zander. A scholar is included among the top collaborators of Serge A.L. Zander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge A.L. Zander. Serge A.L. Zander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 2 | |
| 4 | 155 | |
| 5 | 388 | |
| 6 | 13 | |
| 7 | 24 | |
| 8 | 6 | |
| 9 | 66 | |
| 10 | High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugsbreakdown → | 762 |
About Serge A.L. Zander
Serge A.L. Zander is a scholar working on Oncology, Immunology and Allergy and Infectious Diseases, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), DNA Repair Mechanisms (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Oncology (1.1k citations), Reproductive Medicine (133 citations) and Molecular Biology (1.1k citations). Serge A.L. Zander has collaborated with scholars based in Netherlands, United Kingdom and Denmark. Frequent co-authors include Jos Jonkers, Piet Borst, Sven Rottenberg, Ariena Kersbergen, Janneke E. Jaspers, Aaron Cranston, Mark J. O’Connor, Niall M.B. Martin, Alan Lau and Eline van der Burg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.